China’s Robot IPO Pullback Tests Tesla’s Optimus Ambitions

Chinese regulators are slowing humanoid-robot company listings, raising questions about the commercial demand behind a sector central to Tesla’s growth plans. Reuters reported on September 21 that officials are scrutinizing valuations and revenue tied to state-backed projects.

The move follows Unitree Robotics’ volatile Shanghai debut in August. Its shares surged more than fivefold on the first day, then fell 55% from their peak, according to Reuters.

The stock swing is a warning for companies whose public-market value depends on investor excitement outpacing proven sales. At least six other Chinese humanoid-robot makers are preparing listings, Reuters reported, including AgiBot, Deep Robotics and X Square Robot.

Regulators are asking whether government-backed data centers and other projects reflect demand from independent customers. Reuters reported that one source estimated revenue at some robotics companies could drop 60% to 70% if data-center income were excluded.

The scrutiny lands as Tesla shifts more resources toward robotics. The company raised its 2026 capital-spending plan to more than $25 billion, and has said it is preparing production lines for Optimus, with a long-term goal of producing 1 million robots a year.

That target depends on more than building factories. Tesla will need buyers willing to pay for robots that can perform useful work reliably, while Chinese companies are expanding production and testing commercial uses. Unitree lists its R1 robot from $4,900, though that price alone does not show it can handle the tasks Tesla envisions.

The contrast is a reminder that manufacturing scale and durable customer demand are separate challenges. Tesla investors will be watching for concrete Optimus production milestones and evidence of paid deployments, as well as whether China’s tougher IPO standards spread beyond listings to funding for the sector.